Literature DB >> 2592732

Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species.

K Bachmann1.   

Abstract

Values for the independent kinetic variables, clearance (CL) and volume of distribution (V), for six xenobiotics--antipyrine, ethosuximide, phencyclidine, theophylline, valproic acid and warfarin--were culled from the literature for each of three small subhuman species and for humans, and then allometrically scaled. Scaling was performed in two ways. First, using kinetic data acquired for three small subhuman species and for man, scaled parameters were observed for goodness of fit to a standard allometric expression. Second, scaled parameters were averaged for three subhuman species. Mean scaled kinetic parameters from only three species were used to predict half-life values of the xenobiotics in humans. Finally, predicted percentages of the xenobiotic burdens remaining in humans at the end of four allometrically-predicted half-lives were compared with the expected percentages of remaining xenobiotic based upon four actual half-lives in humans. The results suggest that it may be feasible to estimate, using three small subhuman species, allometrically-derived toxicokinetic parameters of some substances in man with sufficient accuracy to be of practical value.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592732     DOI: 10.1002/jat.2550090509

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  4 in total

Review 1.  The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.

Authors:  I Mahmood; J D Balian
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

2.  Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs.

Authors:  Yeamin Huh; David E Smith; Meihau Rose Feng
Journal:  Xenobiotica       Date:  2011-09-05       Impact factor: 1.908

3.  Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?

Authors:  Gary W Caldwell; John A Masucci; Zhengyin Yan; William Hageman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

4.  Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infection.

Authors:  Adams Amantana; Yali Chen; Shanthakumar R Tyavanagimatt; Kevin F Jones; Robert Jordan; Jarasvech Chinsangaram; Tove C Bolken; Janet M Leeds; Dennis E Hruby
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.